Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07356986 · ClinicalTrials.gov registry record
Stelo Real-time Continuous Glucose Monitor Use Postpartum for Lifelong Optimal Wellness
A clinical trial, sponsored by Oregon Health and Science University.
- Not yet
- Registry status
- 50
- Enrollment target
NCT07356986: Clinical Trial study, sponsored by Oregon Health and Science University.
NCT07356986 is a clinical trial that has not yet begun recruiting, run by Oregon Health and Science University. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07356986 has not yet begun recruiting, sponsored by Oregon Health and Science University.
- NOT YET RECRUITING
- Registry status
- 50 participants
- Enrollment target
Study Summary
The purpose of this prospective observational study is to gather exploratory and practical use data of the Dexcom Stelo Glucose Biosensing System (Stelo), an over-the-counter (OTC) real-time Continuous Glucose Monitoring (CGM) system among patients with Gestational Diabetes Mellitus (GDM) in their most recent pregnancy.
Primary Outcome
24-hour mean glucose based on Stelo Glucose Biosensor readings
Interventions
- DEVICE Dexcom Stelo real-time Continuous Glucose Monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2026-01 |
| Est. Completion | 2027-12 |
What is known before NCT07356986 opens enrollment
NCT07356986 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Dexcom Stelo real-time Continuous Glucose Monitor is the first listed.
NCT07356986 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07356986 about?
NCT07356986 is a clinical study titled "Stelo Real-time Continuous Glucose Monitor Use Postpartum for Lifelong Optimal Wellness". The purpose of this prospective observational study is to gather exploratory and practical use data of the Dexcom Stelo Glucose Biosensing System (Stelo), an over-the-counter (OTC) real-time Continuous Glucose Monitoring (CGM) system among patients with Gestational Diabetes Mellitus (GDM) in their m...
What is the current status of trial NCT07356986?
This trial is currently not yet recruiting. The enrollment target is 50 participants. The study started on 2026-01. Estimated completion is 2027-12.
What interventions are being tested in trial NCT07356986?
The interventions under investigation include: Dexcom Stelo real-time Continuous Glucose Monitor (DEVICE).
Who is sponsoring clinical trial NCT07356986?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia